Dr Pal Previews ASCO 2024 Data in Renal Cell Carcinoma

Sumanta Kumar Pal, MD, FASCO, discusses key biomarker analyses in renal cell carcinoma that will be presented at the 2024 ASCO Annual Meeting.

Related Keywords

Sumanta Kumar Pal ,Kidney Cancer Program ,Therapeutics Research ,Department Of Medical Oncology ,Bladder Cancer Disease Team ,Medical Oncology ,